Coloplast A/S
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Coloplast A/S sits in the top decile of US sponsors by registered trial count (#714 of 15,742 sponsors by registered trial count).
Coloplast A/S: 21 sponsored US clinical trials, none currently recruiting.
Coloplast A/S sponsors 21 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 16 completed. 1 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Surgical Stomas, with 1 trials.
Top-decile sponsor footprint
Coloplast A/S ranks in the top decile of sponsors by registered trial count (#714 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
16 of 20 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
21 total, page 1 of 1
INTIBIA Pivotal Study
NCT05250908
A RCT Evaluating the Clinical Benefit of a Silver Dressing in the Treatment of Venous Leg Ulcers
NCT05923749
Clinical Investigation of an Improved Two-piece Stoma Product for People Living With a Stoma
NCT05652010
A Clinical Investigation Evaluating Peristeen® Performance
NCT05381610
Intermittent Catheterisation on the Bladder Mucosa of Healthy Volunteers With a Prototype Micro Hole Zone Catheter
NCT05224544
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
NCT02675634
A Clinical Investigation Evaluating and Understanding Parameters Affecting the Performance of Ostomy Products
NCT02517541
Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence
NCT02348112
Restorelle® Mesh Versus Native Tissue Repair for Prolapse
NCT02162615
Exair® Versus Native Tissue Repair for Prolapse
NCT02162628
Axis™ Allograft Dermis for Female Pelvic Floor Repair: a Prospective Post Market Study
NCT01541748
Restorelle Direct Fix Anterior and Posterior (A&P) for Female Pelvic Organ Prolapse: A Prospective Post Market Study
NCT01378065
The Altis® Single Incision Sling System for Female Stress Urinary Incontinence Study
NCT01272284
Virtue® Male Sling Fixation Study
NCT01170728
Virtue® Male Incontinence Sling Study
NCT00856778
Coloplast DialogueStudy
NCT00626821
A Feasibility Study of a Fecal Incontinence Management System for Medical Use
NCT00556972
Evaluation of the Coloplast Titan® IPP for Maintaining Penile Length While Treating Erectile Dysfunction (ED)
NCT00731666
Titan® One Touch Release Inflatable Penile Prosthesis
NCT00731939
Comparative Study of Intermittent Catheters and Occurrence of Urinary Tract Infections
NCT00318591
Feasibility Study of a New Fistula Pouching System
NCT00294450
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 1 |
How the Coloplast A/S archive is shaped
21 indexed studies, none listed as recruiting (0% open); 16 completed (76%).
Phase mix: 1 late (III/IV) vs 1 early (I/II) (balanced across stages).
Top condition: Surgical Stomas (1 trial), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Coloplast A/S: archived-pipeline peers nationwide
Peers matched on 21 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Coloplast A/S sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 21 archived trials
- AEterna Zentaris · 21 trials · 0% recruiting
- Amphastar Pharmaceuticals · 21 trials · 5% recruiting
- Apellis Pharmaceuticals · 21 trials · 10% recruiting
- Array Biopharma, now a wholly owned subsidiary of Pfizer · 21 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Coloplast A/S page
21 registered trials is a research-attention snapshot, not an endorsement of Coloplast A/S or any single study.
- None of Coloplast A/S's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Surgical Stomas is the condition Coloplast A/S studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Surgical Stomas trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Coloplast A/S pipeline card: 21 registered trials from official public datasets.Report a data error.